An alarming rise in colorectal cancer among teens is being reported, yet a little-known provision in the Inflation Reduction Act (IRA) is blocking access to new, lifesaving treatments. The article highlights the urgency of addressing this public health crisis and the political hurdles that complicate the development and approval of effective therapies. The situation calls for swift legislative action to ensure that young patients can benefit from innovative treatments without unnecessary delays.
Keep Reading
Add A Comment